• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
WU Qi,SONG Shuyi,CHEN Qimei,YUAN Xiaoqing,LIU Qisong,YIN Lei,YANG Ailin,ZHANG Jiayu.Study on anti-allergic efficacy of KGM and its mechanism prediction based on network pharmacology[J].Journal Of Pharmaceutical Research,2022,41(11):705-708,716[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2256times   Download 2635次 QR Code for this article
Scan with your phone!
KGM组方抗炎抗过敏药效评价及作用机制的网络药理学预测
兀琦1,宋书祎1,陈启梅1,袁晓庆1,刘其耸2,尹雷2,杨爱琳1,张加余1
Font:Larger+|Default|Smaller-
(1.滨州医学院,山东 烟台 264003;2.烟台新时代健康产业有限公司,山东 烟台 265505)
摘要:
目的 评价KGM组方的抗炎抗过敏药效,并对其潜在的作用机制进行预测。方法 利用透明质酸酶活性抑制试验和二甲苯致小鼠耳肿胀模型试验评价KGM的抗炎抗过敏作用,运用网络药理学预测其起效机制。结果 KGM对透明质酸酶的抑制率为41%,对小鼠耳肿胀抑制率约为44%,表明其具有一定的抗炎抗过敏作用。网络药理学预测结果显示,KGM主要组成成分作用于炎症、过敏及免疫相关靶点209个;绘制成分-靶点-疾病相互作用网络图并结合GO与KEGG富集分析发现,GBA、AKR1B1、CASP3、VDR、CA2、CA1、CA12、CA9、ACE、FUCA1、MGAM与SI等是KGM的主要作用靶点,涉及的细胞功能主要包括G蛋白偶联受体信号通路调节、分泌调节、离子输运调节等;涉及的通路主要包括G蛋白偶联受体信号通路、氮代谢、钙离子通道、淀粉和蔗糖代谢、cAMP信号通路等。结论 KGM具有一定的抗炎抗过敏作用,其机制可能与调控G蛋白偶联受体信号通路、钙离子通道、cAMP信号通路等有关。
关键词:  抗炎抗过敏作用  网络药理学  作用机制预测  KGM组方
DOI:10.13506/j.cnki.jpr.2022.11.002
基金项目:山东省泰山学者青年专家项目(No.tsqn202103110);山东省青创人才引育计划(No.10073004);烟台市省级以上领军人才配套支持计划
Publication Date:November 25, 2022
Study on anti-allergic efficacy of KGM and its mechanism prediction based on network pharmacology
WU Qi1,SONG Shuyi1,CHEN Qimei1,YUAN Xiaoqing1,LIU Qisong2,YIN Lei2,YANG Ailin1,ZHANG Jiayu1
(1.Binzhou Medical University, Yantai 264003, China2.Yantai New Era Health Industry Co., Ltd.,Yantai 265505, China)
Abstract:
Objective To evaluate the anti-allergic effect of KGM, and predict the potential mechanism.Methods hyaluronidase activity inhibition experiment and xylene induced ear swelling model experiment were used to verify the anti-allergic effect of KGM in vivo and in vitro, network pharmacology was used to predict its mechanisms of action. Results The inhibitory rate of KGM on hyaluronidase was 41%, and the inhibitory rate of KGM on ear swelling of mice was 44%, which indicated that KGM had some anti-inflammatory and allergic effects. Additionally, the network pharmacology prediction results showed that there are 209 potential targets of the main components of KGM acting on inflammation, allergy and immunity. Through drawing the component-target-disease interaction network map and analyzing the results of GO and KEGG, GBA, AKR1B1, CASP3, VDR, CA2, CA1, CA12, CA9, ACE, FUCA1, MGAM and SI and so on are the main effect targets of KGM, and the cellular functions associated with the targets mainly include G protein-coupled receptor signaling pathway regulation, secretion regulation, ion transport regulation and so on. The pathways associated with the targets mainly include G protein-coupled receptor signaling pathway, nitrogen metabolism, calcium channel, starch and sucrose metabolism, cAMP signaling pathway, and so on. Conclusion KGM had some anti-inflammatory and antiallergic effects, and its mechanism may be related to the regulation of G protein-coupled receptor signaling pathway, calcium channel and cAMP signaling pathway and so on.
Key words:  Anti-inflammatory and allergic effects  Network pharmacology  Prediction of action mechanism  KGM compound
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.